Dehydrocrenatidine
Code | Size | Price |
---|
TAR-T19934-5mg | 5mg | £779.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T19934-50mg | 50mg | £2,842.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T19934-100mg | 100mg | £4,279.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Dehydrocrenatidine is an inhibitor of JAK.
CAS:
65236-62-6
Formula:
C15H14N2O2
Molecular Weight:
254.289
Pathway:
JAK/STAT signaling|Angiogenesis|Apoptosis|Stem Cells|Chromatin/Epigenetic
Purity:
0.98
SMILES:
COc1cccc2c1[nH]c1c(C=C)ncc(OC)c21
Target:
Apoptosis|JAK
References
1. Zhang J, Zhu N, Du Y, Bai Q, Chen X, Nan J, Qin X, Zhang X, Hou J, Wang Q, Yang J. Dehydrocrenatidine is a novel janus kinase inhibitor. Mol Pharmacol. 2015 Apr;87(4):572-81. doi: 10.1124/mol.114.095208. Epub 2015 Jan 12. PubMed PMID: 25583084.